Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science.
The Congressional briefing will be held Tuesday, June 28, on Capitol Hill in Washington, D.C.
The event, organized by the American Association for Cancer Research (AACR), is in conjunction with the National Cancer Moonshot Initiative led by Vice President Joe Biden.
Lovly, who treats lung cancer patients and operates a research laboratory at Vanderbilt-Ingram Cancer Center (VICC), is a recent AACR Career Development Award recipient and is one of five early-career investigators invited to testify.
“I am extremely honored to participate in such an important advocacy forum for cancer research at the national level. There have been many amazing advancements in cancer therapies, and I am excited to share my enthusiasm for cancer research while also promoting the need for continued research to advance our treatment paradigms to make outcomes better for all patients,” Lovly said.
Lovly will discuss translational research, which is designed to speed discoveries developed in the laboratory to patients in the clinic.
The Congressional briefing will also highlight the work of the National Cancer Institute’s (NCI) Blue Ribbon Panel, whose members include Jennifer Pietenpol, Ph.D., executive vice president for Research at Vanderbilt University Medical Center and director of VICC.
